Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

NPA chairman Nick Kaye told the PA news agency that while obesity is "one of the biggest challenges facing" the UK, they are ...

Pharmacy leaders have issued a warning over the online sale of weight-loss jabs insisting there is still a risk to patient ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Wegovy, Mounjaro and Zepbound, may change a person's overall health.The study, published Monday in the journal Nature ...

Semaglutide, sold under the brand names of Ozempic, Rybelsus and Wegovy, is one of the most popular drugs on the market.

The drugs became so popular so fast that manufacturers began running out, and patients scrambled to find Ozempic or Wegovy ...

Research has found that GLP-1 receptors, found in medications like Wegovy and Monjaro, may offer health benefits beyond the ...

Novo Suffers Wegovy Trial Setback as US Plans to Cut Price Patients lost 20.7% of body weight, disappointing investors US plan to target Wegovy in price negotiations hits shares ...